ArticleNeuro-oncology advancesPublished
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma
Regional connection
Verified An author affiliation on the Europe PMC record names Thomas Jefferson University Hospital, with Jefferson Health linked by the institution reference. Affiliation source
- Institutions
- Jefferson Health, Thomas Jefferson University Hospital
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Neuro-oncology advances
- Published
- Topic
- Clinical care
- Subject terms
- Angiogenesis; Glioblastoma; Vascular Endothelial Growth Factor; Cediranib
- PubMed ID
- 38024244
- PubMed Central ID
- PMC10660192
- Open access
- Yes, open
- Added to directory
- Source checked